Recent advancement in breast cancer treatment using CAR T cell therapy:- A review
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology
Reference135 articles.
1. Types of Breast Cancer,2020
2. Breast cancer risk factors: age, genetics & others;[Medical review];Cedars Sinai,2021
3. Finding the keys to the CAR: identifying novel target antigens for T cell redirection immunotherapies;Abbott;Int. J. Mol. Sci.,2020
4. CAR-T cell therapies: an overview of clinical studies supporting their approved use against acute lymphoblastic leukemia and large B-cell lymphomas;Ahmad;Int. J. Mol. Sci.,2020
5. TEM8/ANTXR1-Specific CAR T cells as a targeted therapy for triple-negative breast CancerTEM8 CAR T cells as targeted therapy for TNBC;Ahmed;Cancer Res.,2018
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast Cancer;2024-09-06
2. Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-28
3. Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer;Current Pharmaceutical Biotechnology;2024-07-31
4. Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions;Bioconjugate Chemistry;2024-07-11
5. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer;Molecular Cancer;2024-05-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3